Skip to main content
4DMEDICAL LIMITED logo

4DMEDICAL LIMITED — Investor Relations & Filings

Ticker · 4DX ISIN · AU0000095416 LEI · 9845000A8F12A6A6FD75 ASX Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 546 across all filing types
Latest filing 2023-05-28 Capital/Financing Update
Country AU Australia
Listing ASX 4DX

About 4DMEDICAL LIMITED

https://4dmedical.com/

4DMedical Limited develops non-invasive respiratory imaging solutions centered on its proprietary XV Technology. This platform utilizes advanced algorithms to transform standard X-ray sequences into four-dimensional quantitative data, visualizing regional lung function in motion. The flagship XV Lung Ventilation Analysis Software (XV LVAS) provides clinicians with detailed maps of airflow distribution throughout the respiratory cycle, facilitating the early detection and monitoring of chronic conditions such as COPD, asthma, and interstitial lung disease. By providing objective, high-resolution insights into lung ventilation without the limitations of traditional pulmonary function tests, the company's cloud-based diagnostic tools aim to improve clinical workflows and patient management. The integration of artificial intelligence further enhances its capability to deliver precise, automated lung tissue analysis.

Recent filings

Filing Released Lang Actions
Update - Proposed issue of securities - 4DX 13 pages 50.1KB
Capital/Financing Update Classification · 100% confidence The document is a detailed announcement regarding a proposed issue of securities by 4DMEDICAL LIMITED, including specifics about a securities purchase plan, placement, offer prices, number of securities, conditions, fees, and timetable. It references ASX Listing Rules and includes detailed terms of the securities issuance. The content is regulatory in nature, focused on capital raising activities and compliance with listing rules. It is not a financial report, earnings release, or management discussion. It is not a proxy or voting announcement, nor a legal or governance report. The document is an update to a previous announcement about securities issuance and oversubscription acceptance. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length and detail confirm it is not a brief announcement or a report publication notice, but a substantive update on financing activities.
2023-05-28 English
44Medical unveils VQ product at premier US lung conference 3 pages 427.6KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 23 May 2023 from 4DMedical Limited about unveiling a new product (CT:VQ) at a US lung conference. It discusses technological progress, clinical benefits, and future plans including FDA submission. The content is a corporate announcement about product development and clinical data presentation, not a financial report, earnings release, or regulatory filing. It does not contain financial statements or detailed financial analysis. It is not a report publication announcement since it does not mention an attached report or provide a link to a report. The document is best classified as a general regulatory announcement about product development and clinical progress, fitting the Regulatory Filings (RNS) category as a fallback for miscellaneous announcements that do not fit other categories.
2023-05-22 English
4DMedical granted Authority to Operate at Harry S. Truman VA 2 pages 208.6KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 18 May 2023 from 4DMedical Limited. It announces that the company has been granted Authority to Operate (ATO) at a specific Veterans Hospital site, which is a milestone towards gaining National ATO. The content focuses on a business update regarding regulatory approval and operational authorization rather than financial results, management changes, or detailed financial data. The document is relatively short (4363 characters) and reads as a corporate announcement about a specific operational milestone. There is no indication of financial statements, earnings data, or detailed report content. It is not a report publication announcement since it does not mention any report being attached or published. The nature of the announcement fits best under Regulatory Filings (RNS), which is the fallback category for general regulatory or compliance announcements that do not fit other specific categories.
2023-05-17 English
Ceasing to be a substantial holder 3 pages 128.0KB
Major Shareholding Notification Classification · 100% confidence The document is titled 'Form 605' and is a 'Notice of ceasing to be a substantial holder' under the Corporations Act 2001 Section 671B. It details changes in relevant interests of a substantial holder in voting securities, including dates, nature of changes, and share counts. It also includes an annexure listing shareholders with shares subject to escrow. The content is regulatory in nature, reporting changes in significant share ownership levels, which aligns with the definition of 'Major Shareholding Notification'. The document is not a financial report, earnings release, or management discussion, but a formal notification of shareholding changes. Therefore, the appropriate classification is 'MRQ' (Major Shareholding Notification). The document length (6805 characters) supports it being a full notification rather than a brief announcement or certification.
2023-05-17 English
Change in substantial holding 4 pages 205.4KB
Major Shareholding Notification Classification · 100% confidence The document is titled 'Form 604' and references the Corporations Act 2001, specifically Section 671B, which pertains to the 'Notice of change of interests of substantial holder.' The content details changes in voting power and relevant interests of a substantial shareholder in the company 4DMedical Limited, including dates and share quantities. This form is a regulatory filing used to notify the market and regulators of changes in substantial shareholdings. It is not a financial report, earnings release, or management discussion, but a formal notification of shareholding changes. Therefore, it fits the category of Major Shareholding Notification (MRQ). The document length and detail confirm it is the actual notice, not just an announcement of a report.
2023-05-17 English
Change in substantial holding 4 pages 209.7KB
Major Shareholding Notification Classification · 100% confidence The document is titled 'Form 604' and references the Corporations Act 2001, specifically Section 671B, which pertains to the 'Notice of change of interests of substantial holder.' The content details changes in voting power and relevant interests of a substantial shareholder, Helen Fouras, including dates and share quantities. It also includes information about associates and addresses, signatures, and legal references to the Corporations Act. This form is a regulatory filing notifying the market and regulators about changes in substantial shareholdings, not a financial report, earnings release, or management discussion. It fits the definition of a Major Shareholding Notification, which involves notification of changes in significant share ownership levels crossing thresholds.
2023-05-17 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.